Todd Asset Management LLC Sells 22,499 Shares of Gilead Sciences, Inc. $GILD

Todd Asset Management LLC reduced its stake in Gilead Sciences, Inc. by 3.8% in Q3, selling 22,499 shares, but it remains their 16th largest holding. The biopharmaceutical company recently reported strong Q4 earnings, beat revenue expectations, and raised its FY26 EPS guidance, leading to several analyst target increases and a “Moderate Buy” consensus rating with a $152.50 price target. Gilead also increased its quarterly dividend to $0.82 per share, and institutional investors collectively own 83.67% of the company’s stock.